Recurrent Oropharyngeal Squamous Cell Carcinoma Active Not Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0037158 (Recurrent Oropharyngeal Squamous Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01064479Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckTreatment
NCT00494182Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell CancerTreatment